Your browser doesn't support javascript.
loading
Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake.
Blom, Thomas; Meinsma, Rutger; Rutgers, Marja; Buitenhuis, Corine; Dekken-Van den Burg, Marieke; van Kuilenburg, André B P; Tytgat, Godelieve A M.
Affiliation
  • Blom T; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Meinsma R; Gastroenterology & Metabolism, Department of Clinical Chemistry, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Rutgers M; Gastroenterology & Metabolism, Department of Clinical Chemistry, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Buitenhuis C; Department of Experimental Therapy, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Dekken-Van den Burg M; Department of Experimental Therapy, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Kuilenburg ABP; Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Tytgat GAM; Gastroenterology & Metabolism, Department of Clinical Chemistry, Amsterdam University Medical Center, Amsterdam, The Netherlands.
EJNMMI Res ; 10(1): 78, 2020 Jul 08.
Article in En | MEDLINE | ID: mdl-32642907

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: EJNMMI Res Year: 2020 Document type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: EJNMMI Res Year: 2020 Document type: Article Affiliation country: Netherlands